Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
OrigiMed and Takeda Announced Partnership to Accelerate R&D and Commercialization of Innovative Medicines 2020-11-11 21:26
I-Mab Announces Preclinical Data on Differentiated Anti-C5aR Antibody TJ210/MOR210 at SITC 2020 2020-11-11 21:00
Asieris Announces First Patient Administration in the Global Phase III Clinical Trial for APL-1702 2020-11-11 17:08
Bioheng Announced Oral Presentation of Its Preliminary Results of CRISPR-Engineered Allogeneic CAR-T for r/r B-ALL Treatment at 2020 ASH Meeting 2020-11-10 22:30
Volition Veterinary Presents Expert Report Ahead of First Product Launch 2020-11-10 21:00
I-Mab Reports Phase 1 Clinical Trial Data of Highly Differentiated Anti-CD47 Monoclonal Antibody Lemzoparlimab at the 2020 SITC Annual Meeting 2020-11-09 21:12
GenScript Receives FDA Emergency Use Authorization for World's First SARS-CoV-2 Neutralizing Antibody Detection Kit 2020-11-09 20:30
TaiGen Partners with GPCR to develop Burixafor & Taigexyn(R) 2020-11-09 18:22
Inmagene Biopharmaceuticals closed $21 million Series B financing, making the total raised to date over $40 million 2020-11-09 08:00
CARE GA Receives Study May Proceed Letter from US FDA to Initiate Phase II Clinical Trial of Senhwa's Silmitasertib in COVID-19 Patients 2020-11-06 22:00
Daewoong Pharmaceutical Announces Publication of Novel P-CAB Fexuprazan Phase 1 Bridging Study 2020-11-06 22:00
New Drug for Gastrointestinal Stromal Tumours (GIST) to be Launched in Australia, New Zealand and South East Asia Following Distribution Agreement 2020-11-06 05:30
Porton Biologics Launched Gene and Cell Therapy CDMO Platform to Rank Among the Top of Pharma Solutions Platforms 2020-11-05 15:35
Asieris Announces Approval of its Phase III Trial of a Novel Single Oral Agent as First-line Treatment for Non-Muscle Invasive Bladder Cancer (NMIBC) 2020-11-05 13:59
Senhwa Announces Multiple IND application submissions to U.S. FDA for Silmitasertib as a Potential Treatment for COVID-19 2020-11-02 22:00
PolyActiva appoints Tracy Valorie, ophthalmic industry expert and former Bausch + Lomb executive, to its Board of Directors 2020-10-30 20:00
Daewoong Pharmaceutical Partners with Tufts Medical Center for Phase 2 Clinical Trial with Niclosamide 2020-10-29 21:00
Yuyu Pharma Announces the Introduction of Anti-Bribery Management System to meet Global Standards 2020-10-28 21:00
I-Mab Announces Upcoming Participation at November Conferences 2020-10-28 20:00
Yiling Pharmaceutical: Revenue and Net Profit Attributable to the Parent Company for the First Three Quarters Already Exceeded the Full Year 2019 2020-10-28 17:04
1 119 120 121 122 123 170